Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spezial Report: NASDAQ-FinTech mit 3.000% Wachstum und 500% Kurs-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
1.269 Leser
Artikel bewerten:
(2)

Life Science Analytics Market worth $47.5 billion | MarketsandMarkets.

CHICAGO, Feb. 10, 2023 /PRNewswire/ -- Life Science Analytics Market in terms of revenue was estimated to be worth $27.1 billion in 2022 and is poised to reach $47.5 billion by 2027, growing at a CAGR of 11.8% from 2022 to 2027 according to a new report by MarketsandMarkets. The life science analytics market is mainly driven by factors such as rising technological advancements in analytical solutions and increasing adoption of analytics for sales and marketing applications. However, high implementation costs and data privacy concerns are expected to restrain the growth of this market to a certain extent.

MarketsandMarkets Logo

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653

Browse in-depth TOC on "Life Science Analytics Market"
211 - Tables
45 - Figures
251 - Pages

Life Science Analytics Market Scope:

Report Coverage

Details

Market Revenue in 2022

$27.1 billion

Estimated Value by 2027

$47.5 billion

Growth Rate

Poised to grow at a CAGR of 11.8%

Market Size Available for

2020-2027

Forecast Period

2022-2027

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Type, Component, Delivery Model, Application, End User, and Region

Geographies Covered

North America (US and Canada), Asia (Japan, China, India, and RoA), Europe (Germany, UK, France,Italy, and RoE), and the Rest of the World

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Big data analytics for R&D productivity

Key Market Drivers

Rising pressure to curb healthcare spending

"Descriptive analytics type segment is expected to account for the largest share of the life science analytics market in 2022"

Based on type, the life science analytics market is bifurcated into descriptive analytics, predictive analytics, and prescriptive analytics. In 2022, the descriptive analytics segment was expected to hold the largest share of this market. The large share of this segment is attributed to the major usage of descriptive analytics by stakeholders to gain a clearer understanding of past trends and events arising in real-time.

"Services segment to grow at the highest CAGR in the life science analytics market during the forecast period, by component"

Based on component, the life science analytics market is segmented into services and software. In 2022, the services segment was expected to account for the largest market share of the life science analytics market. This segment is also expected to grow at the highest CAGR during the forecast period, primarily due to the frequent need for services such as software upgrades and maintenance.

"Research & development segment is expected to account for the largest share of the life science analytics market in 2022"

Based on application, the life science analytics market is divided into research & development, sales & marketing, regulatory compliance, supply chain optimization, and pharmacovigilance. In 2022, research & development is expected to account for the largest share of the life science analytics market. However, the sales & marketing segment is estimated to register the highest growth during the forecast period. Factors such as e increasing implementation of analytics by life science companies to support sales and marketing campaigns and increasing importance of post-marketing surveillance are driving the growth of this segment.

"North America is expected to hold the largest share of the life science analytics market in 2022"

Based on region, the life science analytics market is divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Factors such as growing adoption of IT in the life science industry, rising pressure to reduce healthcare costs and presence of leading players are driving the growth in North American market.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174990653

Life Science Analytics Market Dynamics:

Drivers:

  1. Technological advancements
  2. Big data in the life science industry
  3. Growing adoption of analytics solutions in clinical trials
  4. Increasing adoption of analytics for sales and marketing applications
  5. Need for improved data standardization
  6. Increasing prevalence of chronic diseases
  7. Growing pressure to curb healthcare spending and the need for improved patient outcomes

Restraints:

  1. High implementation costs

Opportunities:

  1. Increasing focus on value-based medicine
  2. Use of analytics in precision and personalized medicine
  3. Use of big data analytics to increase R&D productivity
  4. Emergence of social media and its impact on the life science industry

Challenges:

  1. Data privacy issues
  2. Data integration in the life science ecosystem
  3. Dearth of skilled personnel

Key Market Players:

Prominent players in this market include Oracle (US), IBM (US), SAS Institute Inc. (US), Accenture (Ireland), IQVIA Inc, (US), Cognizant (US), Wipro (India), Allscripts Healthcare, LLC (US), Optum, Inc. (US), Microsoft (US), MaxisIT (US), ExlService Holdings, Inc. (US), Cerner Corporation (US), Cotiviti, Inc. (US), Inovalon (US), CitiusTech Inc (US), Saama Technologies, LLC. (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot Inc. (US), Alteryx, Inc. (US), Sisense Inc. (US), Amazon Web Services, Inc., and Veeva Systems (US).

Recent Developments:

  • In November 2022, IQVIA (US) collaborated with Clalit (Israel) to launch the first Prime Site in the country. The collaboration will allow focus on the future of innovation, including precision medicine and the delivery of data-driven trials.
  • In June 2022, SAS Institute Inc. (US) entered into an agreement with Gunvatta (US) to expedite clinical trials and FDA reporting through the SAS Life Science Analytics Framework on Azure.
  • In March 2022, Wipro Limited (India) partnered with Pandorum (India). This partnership will provide insights into the potential outcomes of specific formulations, apply advanced algorithms to predict and enhance the efficiency of therapeutics, and improve clinical study design.
  • In January 2021, Oracle (US) collaborated with Cognizant (US) to integrate technologies to reduce study startup time and streamline the management of clinical trials.
  • In May 2019, SAS Institute Inc. (US) opened its SAS Cloud offering in an Amazon Web Services Data Center in Singapore.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174990653

Browse Adjacent Market: Healthcare IT Market Research Reports & Consulting

Related Reports:

Healthcare Analytics Market - Global Forecasts to 2027

Healthcare Analytical Testing Services Market - Global Forecasts to 2027

Telehealth & Telemedicine Market - Global Forecasts to 2027

Healthcare IT Market - Global Forecasts to 2027

Healthcare Fraud Analytics Market - Global Forecasts to 2026

About MarketsandMarkets:

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/life-science-analytic-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/life-science-analytics.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/life-science-analytics-market-worth-47-5-billion--marketsandmarkets-301743867.html

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2023 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.